Treatability by cryotherapy in a screen-and-treat strategy

Journal of Lower Genital Tract Disease

Volumn 13, Issue 3, 2009, Pages 174-181

  Gage, Julia C ^a   Rodriguez, Ana Cecilia ^b   Schiffman, Mark ^a   Garcia, Francisco M ^c   Long, Rodney L ^d   Budihas, Scott R ^d   Herrero, Rolando ^b   Burk, Robert D ^e   Jeronimo, Jose ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Proyecto Epidemiologico Guanacaste   (Costa Rica)

^c UNIVERSITY OF ARIZONA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f Program for Appropriate Technology in Health   (United States)

Author keywords

Cervical intraepithelial neoplasia; Cryotherapy; Human papillomavirus; Low resource settings; Mass screening

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CRYOTHERAPY; CYTOLOGY; DIAGNOSTIC IMAGING; FEMALE; GYNECOLOGY; HISTOLOGY; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; POLYP; PRECANCER; ULCER; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE ENDOCERVIX; WART VIRUS;

ADULT; COSTA RICA; CRYOTHERAPY; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 68749108634     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181909f30     Document Type: Article

References (21)

1. Ferlay J. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. [2.0]. Lyon, France, IARC. IARC CancerBase No. 5; 2004.
2. Miller AB, Nazeer S, Fonn S, Brandup-Lukanow A, Rehman R, Cronje H, et al. Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000; 86:440-447 (Pubitemid 30187509)
3. Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, et al. Cervical cancer control, priorities and new directions. Int J Cancer 2004;108:329-333 (Pubitemid 37549596)
4. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in lowresource settings: clinical benefits and cost-effectiveness. JAMA 2001;285:3107-3115 (Pubitemid 32586089)
5. Qiao Y, Sellors JW, Eder PS, Bao Y, Lim JM, Zhao F, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008;9:929-936
6. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999; 354:20-25 (Pubitemid 29304297)
7. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-3114 (Pubitemid 34016525)
8. Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med 2005;353:2101-2104
9. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-284 (Pubitemid 28125180)
10. Muñoz N, Mendez F, Posso H, Molano M, van den Brule AJ, Ronderos M, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004;190:2077-2087 (Pubitemid 39636354)
11. Denny L, Kuhn L, De Souza M, Pollack AE, DupreeW, Wright TC Jr. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005;294:2173-2181 (Pubitemid 41571134)
12. Bratti MC, Rodriguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica. Rev Panam Salud Publica 2004;15:75-89.
13. Herrero R, Schiffman MH, Bratti C, Hildesheim A, Balmaceda I, Sherman ME, et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica 1997;1:362-375 (Pubitemid 27428425)
14. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005;191: 1796-1807 (Pubitemid 40705385)
15. Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol. 2002;68:417-423
16. Schneider DL, Herrero R, Bratti C, Greenberg MD, Hildesheim A, Sherman ME, et al. Cervicography screening for cervical cancer among 8460 women in a high-risk population. Am J Obstet Gynecol 1999;180:290-298 (Pubitemid 29093855)
17. Jeronimo J, Long LR, Neve L, Michael B, Antani S, Schiffman M. Digital tools for collecting data from cervigrams for research and training in colposcopy. J Low Genit Tract Dis 2006;10:16-25. (Pubitemid 44384285)
18. Massad LS, Jeronimo J, Schiffman M. Interobserver agreement in the assessment of components and colposcopic grading. Obstet Gynecol 2008;111:1279-84.
19. Blumenthal PD, Gaffikin LG, Deganus S, Lewis R, Emerson M, Adadevoh S, et al. Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol 2007;196:407.e1-8
20. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 2003;361:814-820 (Pubitemid 36331843)
21. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP. Management of cryotherapyineligible women in a "screen-and- treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol 2008;110:402-7.